We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The company has entered into multiple manufacturing pacts aimed at ramping up production, including with Emergent BioSolutions, Catalent and Merck. Read More
Johnson & Johnson (J&J) said it expects to deliver 20 million doses of its COVID-19 vaccine for the U.S. by the end of March, as officials nationwide continued to complain of severely limited supplies of the single-shot vaccine. Read More
AbbVie has filed a lawsuit alleging that Iceland-based biosimilar developer Alvotech recruited a former AbbVie employee to steal trade secrets in order to produce a biosimilar of AbbVie’s blockbuster arthritis drug Humira (adalimumab). Read More
The Russian Direct Investment Fund (RDIF) and Indian contract manufacturer Stelis Biopharma have partnered to produce 200 million doses of the Sputnik V COVID-19 vaccine. Read More
A letter to vaccination sites in the UK has cautioned that supplies of COVID-19 vaccines will be tight for about four weeks starting near the end of the month, but Pfizer has offered assurance that it is on track to meet its supply commitments on time. Read More
The European Commission has announced that it expects to receive approximately 200 million doses of Pfizer/BioNTech’s two-dose COVID-19 vaccine in the second quarter, giving hope that the EU may reach its inoculation goals on time despite serious setbacks to vaccine deliveries. Read More
Nearly two dozen attorneys general (AG) have come out against a $10 billion bankruptcy proposal put forth by Purdue Pharma to settle thousands of opioid lawsuits, calling it an improvement over the original plan but still inadequate in the compensation it provides. Read More
France, Italy and Germany have become the latest European countries to halt inoculations with AstraZeneca’s COVID-19 vaccine after 37 cases of blood clots were reported, joining an increasing number of other member states in temporarily putting them on pause as a safety review is conducted. Read More